HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1.

Abstract
The ribonucleotide reductase (ribonucleoside-diphosphate reductase; EC 1.17.4.1) induced by herpes simplex virus type 2 infection of serum-starved BHK-21 cells was purified to provide a preparation practically free of both eucaryotic ribonucleotide reductase and contaminating enzymes that could significantly deplete the substrates. Certain key properties of the herpes simplex virus type 2 ribonucleotide reductase were examined to define the extent to which it resembled the herpes simplex virus type 1 ribonucleotide reductase. The herpes simplex virus type 2 ribonucleotide reductase was inhibited by ATP and MgCl2 but only weakly inhibited by the ATP X Mg complex. Deoxynucleoside triphosphates were at best only weak inhibitors of this enzyme. ADP was a competitive inhibitor (K'i, 11 microM) of CDP reduction (K'm, 0.5 microM), and CDP was a competitive inhibitor (K'i, 0.4 microM) of ADP reduction (K'm, 8 microM). These key properties closely resemble those observed for similarly purified herpes simplex virus type 1 ribonucleotide reductase and serve to distinguish these virally induced enzymes from other ribonucleotide reductases.
AuthorsD R Averett, P A Furman, T Spector
JournalJournal of virology (J Virol) Vol. 52 Issue 3 Pg. 981-3 (Dec 1984) ISSN: 0022-538X [Print] United States
PMID6092726 (Publication Type: Journal Article)
Chemical References
  • Cytidine Diphosphate
  • Adenosine Triphosphate
  • Ribonucleotide Reductases
  • Magnesium
Topics
  • Adenosine Triphosphate (pharmacology)
  • Cytidine Diphosphate (metabolism)
  • Kinetics
  • Magnesium (pharmacology)
  • Ribonucleotide Reductases (antagonists & inhibitors, isolation & purification)
  • Simplexvirus (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: